Anti-MLLT11 antibody [CHCR115]
- RabMAb
- Recombinant
- 20ul selling size
- 각 태그의 뜻
5
(3 리뷰들)
|
(8 제품이 사용된 논문 )
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MLLT11 antibody [CHCR115] (AB109016)
Immunohistochemical analysis of MLLT11 expression in paraffin-embedded Human thymus tissue using ab109016 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-MLLT11 antibody [CHCR115] (AB109016)
All lanes:
Western blot - Anti-MLLT11 antibody [CHCR115] (ab109016) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
Molt4 cell lysate at 10 µg
Predicted band size: 10 kDa,36 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-MLLT11 antibody [CHCR115] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (8)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Cancer medicine 14:e70658 PubMed40062505
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:15988 PubMed38987552
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38203610
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:889351 PubMed36033495
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 11:2637-2653 PubMed34249419
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 13:523 PubMed31849612
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cells 8: PubMed31671695
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 11:312-322 PubMed29858066
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com